Patents by Inventor Yingchao CHENG

Yingchao CHENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RET inhibitors, pharmaceutical compositions and uses thereof
    Patent number: 12312348
    Abstract: A RET inhibitor, a pharmaceutical composition thereof and uses thereof. In particular, the present invention provides a compound having Formula (I) or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof. The invention also relates to a pharmaceutical composition including the compound, and uses of the compound and pharmaceutical composition thereof for the preparation of a medicament, in particular for treatment and prevention of RET-related diseases and conditions, including cancer, irritable bowel syndrome, and/or pain associated with irritable bowel syndrome.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: May 27, 2025
    Assignee: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Hongming Xie, Ming Luo, Jianli Wu, Yingjun Zhang, Yingchao Cheng
  • RET inhibitors, pharmaceutical compositions and uses thereof
    Patent number: 12209085
    Abstract: A RET inhibitor, a pharmaceutical composition thereof and uses thereof including a compound having Formula (I) or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof. Furthermore, a pharmaceutical composition including the compound, and uses of the compound and pharmaceutical composition thereof in the manufacture of a medicament for treatment and prevention of RET-related diseases and conditions, including cancer, irritable bowel syndrome, and/or pain associated with irritable bowel syndrome.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: January 28, 2025
    Assignee: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Hongming Xie, Ming Luo, Jianli Wu, Yingjun Zhang, Yingchao Cheng
  • RET INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
    Publication number: 20220135557
    Abstract: A RET inhibitor, a pharmaceutical composition thereof and uses thereof including a compound having Formula (I) or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof. Furthermore, a pharmaceutical composition including the compound, and uses of the compound and pharmaceutical composition thereof in the manufacture of a medicament for treatment and prevention of RET-related diseases and conditions, including cancer, irritable bowel syndrome, and/or pain associated with irritable bowel syndrome.
    Type: Application
    Filed: December 6, 2019
    Publication date: May 5, 2022
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Hongming XIE, Ming LUO, Jianli WU, Yingjun ZHANG, Yingchao CHENG
  • RET INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
    Publication number: 20220119382
    Abstract: A RET inhibitor, a pharmaceutical composition thereof and uses thereof. In particular, the present invention provides a compound having Formula (I) or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof. The invention also relates to a pharmaceutical composition including the compound, and uses of the compound and pharmaceutical composition thereof for the preparation of a medicament, in particular for treatment and prevention of RET-related diseases and conditions, including cancer, irritable bowel syndrome, and/or pain associated with irritable bowel syndrome.
    Type: Application
    Filed: December 6, 2019
    Publication date: April 21, 2022
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Hongming XIE, Ming LUO, Jianli WU, Yingjun ZHANG, Yingchao CHENG